当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:164.57亿  总市值:224.39亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金11,993,189,120.8654,627,677,371.0738,970,031,481.4624,947,508,365.85
收到的税费返还575,688.96394,942.14533,685.18286,278.54
收到其他与经营活动有关的现金114,925,050.64720,290,246.78589,254,131.68383,300,949.39
经营活动现金流入的平衡项目0000
经营活动现金流入小计12,108,689,860.4655,348,362,559.9939,559,819,298.3225,331,095,593.78
购买商品、接受劳务支付的现金13,202,038,549.7649,548,843,506.3437,984,574,330.8824,770,668,013.22
支付给职工以及为职工支付的现金243,185,245.23834,748,235.09645,376,595.58451,503,135.68
支付的各项税费401,871,352.891,479,571,642.981,126,539,537.56799,136,706.34
支付其他与经营活动有关的现金154,770,431.481,826,079,651.76833,173,466.39375,766,082.62
经营活动现金流出的平衡项目0000
经营活动现金流出小计14,001,865,579.3653,689,243,036.1740,589,663,930.4126,397,073,937.86
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-1,893,175,718.91,659,119,523.82-1,029,844,632.09-1,065,978,344.08
二、投资活动产生的现金流量:
收回投资收到的现金3,139,870.6422,922,454.7222,922,454.7218,561,622.51
取得投资收益收到的现金-23,752,710.763,199,932.893,186,220
处置固定资产、无形资产和其他长期资产收回的现金净额35,080387,130347,43085,640
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,174,950.6447,062,295.4826,469,817.6121,833,482.51
购建固定资产、无形资产和其他长期资产支付的现金7,353,156.13130,772,379.16100,543,198.6760,349,073.89
投资支付的现金--1,375,7001,375,700
支付其他与投资活动有关的现金-2,500,000,00066,050,00166,050,001
投资活动现金流出的平衡项目0000
投资活动现金流出小计7,353,156.132,630,772,379.16167,968,899.67127,774,774.89
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-4,178,205.49-2,583,710,083.68-141,499,082.06-105,941,292.38
三、筹资活动产生的现金流量:
取得借款收到的现金100,000,000315,981,517.06283,109,437.63154,586,850.23
筹资活动现金流入平衡项目0000
筹资活动现金流入小计100,000,000315,981,517.06283,109,437.63154,586,850.23
偿还债务支付的现金168,409,692.671,033,278,332.44267,256,996.13176,055,075.23
分配股利、利润或偿付利息支付的现金8,763,561.7745,851,590.69758,672,424.12733,820,077.19
其中:子公司支付给少数股东的股利、利润-63,420,628.9929,605,711.3628,733,351.86
支付其他与筹资活动有关的现金49,359,766.2119,185,020.28728,096,814.38391,334,317.85
筹资活动现金流出平衡项目0000
筹资活动现金流出小计226,533,020.571,898,314,943.411,754,026,234.631,301,209,470.27
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-126,533,020.57-1,582,333,426.35-1,470,916,797-1,146,622,620.04
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-2,023,886,944.96-2,506,923,986.21-2,642,260,511.15-2,318,542,256.5
加:期初现金及现金等价物余额8,291,394,056.9610,798,318,043.1710,798,318,043.1710,798,318,043.17
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额6,267,507,1128,291,394,056.968,156,057,532.028,479,775,786.67
补充资料:
净利润-2,129,780,565.04-1,063,673,008.77
资产减值准备-1,066,320.03-4,052,580.83
固定资产和投资性房地产折旧-71,391,097.9-36,852,425.29
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,391,097.9-36,852,425.29
无形资产摊销-47,240,380.75-22,465,996.92
长期待摊费用摊销-9,527,114.56-4,189,464.4
处置固定资产、无形资产和其他长期资产的损失-186,992.44-54,073.85
固定资产报废损失-3,777.24-23,203.27
公允价值变动损失-18,201,818.94--
财务费用-33,655,840.77-15,565,603.17
投资损失--550,281,293.66--240,328,388.92
递延所得税--27,785,122.48-14,872,073
其中:递延所得税资产减少--25,194,866.71-14,113,114.79
递延所得税负债增加--2,590,255.77-758,958.21
存货的减少--993,860,192.72--1,000,081,673.47
经营性应收项目的减少--442,419,289.56--2,212,606,663.11
经营性应付项目的增加-1,217,684,408.04-1,115,300,974.9
其他---4,206,210.33
现金的期末余额-8,291,394,056.96-8,479,775,786.67
减:现金的期初余额-10,798,318,043.17-10,798,318,043.17
公告日期2025-04-252025-03-202024-10-242024-08-22
审计意见(境内)标准无保留意见
TOP↑